Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Pemetrexed or Nab-paclitaxel With Pembrolizumab in Elderly (>/= 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT04754815 is registered in ClinicalTrials.gov with Shirish Gadgeel as lead sponsor.

NCT NCT04754815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04754815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Pemetrexed or Nab-paclitaxel With Pembrolizumab in Elderly (>/= 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Shirish Gadgeel
Phase
Phase 2
Overall status
Withdrawn
Start date
April 1, 2021
Completion date
April 1, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lung non-small cell carcinoma, non small cell lung cancer, pd-l1 gene mutation